Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Gynecology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 135 articles:
HTML format



Single Articles


    December 2020
  1. CLARKE C
    Abortion and The Lancet's call to arms.
    Lancet. 2020;394:2241.
    PubMed    


    May 2020
  2. WHITEHEAD CL, Walker SP
    Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.
    Lancet. 2020 May 13. pii: S0140-6736(20)31029.
    PubMed    


    April 2020
  3. PANCHAUD A, Favre G, Pomar L, Vouga M, et al
    An international registry for emergent pathogens and pregnancy.
    Lancet. 2020 Apr 27. pii: S0140-6736(20)30981.
    PubMed    


    March 2020
  4. CHEN H, Guo J, Wang C, Luo F, et al
    Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.
    Lancet. 2020;395:809-815.
    PubMed     Abstract available


  5. QIAO J
    What are the risks of COVID-19 infection in pregnant women?
    Lancet. 2020;395:760-762.
    PubMed    


  6. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    


    February 2020
  7. BURKI T
    UNAIDS and IAEA join forces on HIV and cervical cancer.
    Lancet. 2020;395:484.
    PubMed    


  8. THE LANCET
    Appropriate care for pregnant women in Ebola outbreaks.
    Lancet. 2020;395:468.
    PubMed    


  9. THE LANCET
    Preventing teenage pregnancies in Brazil.
    Lancet. 2020;395:468.
    PubMed    


  10. TANIGUCHI Y, Nishikawa H, Maeda N, Terada Y, et al
    Breathlessness, pleural effusions, fibromas, and Meigs syndrome: look beyond the chest and don't delay!
    Lancet. 2020;395:e32.
    PubMed    


  11. FAVRE G, Pomar L, Musso D, Baud D, et al
    2019-nCoV epidemic: what about pregnancies?
    Lancet. 2020 Feb 6. pii: S0140-6736(20)30311.
    PubMed    


  12. THE LANCET
    Eliminating cervical cancer.
    Lancet. 2020;395:312.
    PubMed    


  13. UZOIGWE CE
    No global consensus among doctors or society on abortion.
    Lancet. 2020;395:e17.
    PubMed    


  14. DUHIG K, Myers J, Seed PT, Shennan AH, et al
    Placental growth factor testing in suspected pre-eclampsia - Authors' reply.
    Lancet. 2020;395:336-337.
    PubMed    


  15. KERMACK AJ, Stocker LJ, Coleman M
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335-336.
    PubMed    


  16. TANNER M, Mol BW
    Placental growth factor testing in suspected pre-eclampsia.
    Lancet. 2020;395:335.
    PubMed    


  17. PHUMAPHI J, Gautam KC, Mason E
    Increased production and comprehensive guidelines needed for HPV vaccine.
    Lancet. 2020;395:319-321.
    PubMed    


    January 2020
  18. CANFELL K, Kim JJ, Brisson M, Keane A, et al
    Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30157.
    PubMed     Abstract available


  19. BRISSON M, Kim JJ, Canfell K, Drolet M, et al
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30068.
    PubMed     Abstract available


  20. TSU VD
    Cervical cancer elimination: are targets useful?
    Lancet. 2020 Jan 30. pii: S0140-6736(20)30219.
    PubMed    


  21. HOFFMAN MK, Goudar SS, Kodkany BS, Metgud M, et al
    Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;395:285-293.
    PubMed     Abstract available


  22. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    


  23. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    


    November 2019
  24. LYERLY AD
    Dolutegravir: advancing ethical research in pregnancy.
    Lancet. 2019;394:1972-1974.
    PubMed    


  25. CLAMP AR, James EC, McNeish IA, Dean A, et al
    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32259.
    PubMed     Abstract available


  26. ESKANDER RN, Monk BJ
    Moving beyond cytotoxic drug dosing in ovarian cancer.
    Lancet. 2019 Nov 29. pii: S0140-6736(19)32948.
    PubMed    


  27. CERDEIRA AS, Tome M, Moore N, Lim L, et al
    Seeing red degeneration in uterine fibroids in pregnancy: proceed with caution.
    Lancet. 2019;394:e37.
    PubMed    


    October 2019
  28. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    PubMed    


  29. MILLER D
    Hyaluronan-selected sperm should not be considered an add-on - Author's reply.
    Lancet. 2019;394:1320.
    PubMed    


  30. PARMEGIANI L
    Hyaluronan-selected sperm should not be considered an add-on.
    Lancet. 2019;394:1319-1320.
    PubMed    


    September 2019
  31. SUGIMURA K, Sasaki O, Shinoda M, Kawasaki S, et al
    Catamenial pneumothorax: a cause of monthly breathlessness.
    Lancet. 2019;394:952.
    PubMed    


  32. SINGH S, Bougie O
    HEALTH for heavy menstrual bleeding: real-world implications.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)32086.
    PubMed    


  33. COOPER K, Breeman S, Scott NW, Scotland G, et al
    Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.
    Lancet. 2019 Sep 12. pii: S0140-6736(19)31790.
    PubMed     Abstract available


    August 2019
  34. KOTSOPOULOS J
    Menopausal hormones: definitive evidence for breast cancer.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31901.
    PubMed    



  35. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available


  36. BERAL V, Peto R, Pirie K, Reeves G, et al
    Menopausal hormone therapy and 20-year breast cancer mortality.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)32033.
    PubMed    


  37. CHAPPELL LC, Brocklehurst P, Green ME, Hunter R, et al
    Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31963.
    PubMed     Abstract available


  38. STAFF AC
    Long-term cardiovascular health after stopping pre-eclampsia.
    Lancet. 2019 Aug 28. pii: S0140-6736(19)31993.
    PubMed    


  39. LAWRIE TA
    Prepregnancy calcium supplementation and pre-eclampsia - Author's reply.
    Lancet. 2019;394:e8.
    PubMed    


  40. MAEDA Y, Suzuki Y, Yamamoto K, Tanimoto T, et al
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e7.
    PubMed    


  41. PONZETTO A, Figura N, Riva P
    Prepregnancy calcium supplementation and pre-eclampsia.
    Lancet. 2019;394:e6.
    PubMed    


  42. HAIGH A, Haigh K
    Coroners' investigations of stillbirths.
    Lancet. 2019;394:564.
    PubMed    


  43. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    PubMed    


  44. CHAPPELL LC, Bell JL, Smith A, Linsell L, et al
    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31270.
    PubMed     Abstract available


  45. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    PubMed     Abstract available


  46. MARSCHALL HU
    Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31607.
    PubMed    


    July 2019
  47. BURKI T
    Northern Ireland likely to legalise abortion.
    Lancet. 2019;394:290.
    PubMed    


  48. HEMIDA R, van Doorn HC
    Avoid making a mountain out of an invasive hydatidiform mole: do a pregnancy test!
    Lancet. 2019;394:e2.
    PubMed    


  49. CHATTERJEE P
    Hysterectomies in Beed district raise questions for India.
    Lancet. 2019;394:202.
    PubMed    


    June 2019
  50. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    PubMed    


  51. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    PubMed     Abstract available


  52. SMIT JG
    Ongoing pregnancy as the primary outcome for the inSIGHT study.
    Lancet. 2019;393:2389.
    PubMed    



  53. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    PubMed     Abstract available


    May 2019
  54. THE LANCET
    We must all support women in the fight for abortion.
    Lancet. 2019;393:2099.
    PubMed    


  55. JAFFE S
    Legal battles over abortion heat up in the USA.
    Lancet. 2019;393:1923-1924.
    PubMed    


  56. LI A
    Northern Ireland deadlock impedes abortion rights progress.
    Lancet. 2019;393:1794.
    PubMed    


  57. BUJOLD E, Chaillet N, Kingdom J
    Placental growth factor testing for suspected pre-eclampsia.
    Lancet. 2019;393:1775-1776.
    PubMed    


  58. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    PubMed    


  59. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    PubMed     Abstract available


    April 2019
  60. THE LANCET
    Progress on investigating stillbirths.
    Lancet. 2019;393:1386.
    PubMed    


  61. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    PubMed     Abstract available


    March 2019
  62. THE LANCET
    Gestational diabetes in England: cause for concern.
    Lancet. 2019;393:1262.
    PubMed    


  63. WEI D, Liu JY, Sun Y, Shi Y, et al
    Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
    Lancet. 2019;393:1310-1318.
    PubMed     Abstract available


  64. LHEUREUX S, Gourley C, Vergote I, Oza AM, et al
    Epithelial ovarian cancer.
    Lancet. 2019;393:1240-1253.
    PubMed     Abstract available


  65. WATSON K
    Abortion as a moral good.
    Lancet. 2019;393:1196-1197.
    PubMed    


  66. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    PubMed    


  67. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    PubMed     Abstract available


  68. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed    


    February 2019
  69. KLEBANOFF MA
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    PubMed    


  70. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    PubMed     Abstract available


  71. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    PubMed    


  72. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    PubMed    


  73. UZOIGWE CE
    Abortion in Argentina.
    Lancet. 2019;393:744-745.
    PubMed    


  74. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    PubMed     Abstract available


  75. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    PubMed    


  76. REPPING S
    Evidence-based medicine and infertility treatment.
    Lancet. 2019;393:380-382.
    PubMed    


  77. MILLER D, Pavitt S, Sharma V, Forbes G, et al
    Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
    Lancet. 2019;393:416-422.
    PubMed     Abstract available


    January 2019
  78. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
    Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2019;393:330-339.
    PubMed     Abstract available


  79. BUJOLD E, Hyett J
    Calcium supplementation for prevention of pre-eclampsia.
    Lancet. 2019;393:298-300.
    PubMed    


  80. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    PubMed     Abstract available


  81. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    PubMed    


    December 2018
  82. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
    The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
    Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
    PubMed     Abstract available


  83. DIAZ-GARCIA C, Pellicer A
    Uterus transplantation from a deceased donor.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
    PubMed    


  84. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
    Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
    PubMed     Abstract available


    November 2018
  85. THE LANCET
    Addressing preventable stillbirth and brain injury.
    Lancet. 2018;392:2238.
    PubMed    


    October 2018
  86. FARQUHAR C
    Unexplained infertility - Authors' reply.
    Lancet. 2018;392:1517.
    PubMed    


  87. GLEICHER N, Kuhnir VA, Barad DH
    Unexplained infertility.
    Lancet. 2018;392:1516-1517.
    PubMed    


  88. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Abstract available


  89. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed    


  90. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Abstract available


  91. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed    


    September 2018
  92. TEMMERMAN M, Lawn JE
    Stillbirths count, but it is now time to count them all.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
    PubMed    


  93. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
    Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
    PubMed     Abstract available


    August 2018
  94. GRESSLER LE, Titus-Glover D, Shaya FT
    Treatment modalities for pregnant women with opioid use disorder.
    Lancet. 2018;392:551.
    PubMed    


  95. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed    


    July 2018
  96. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    HIV.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    PubMed     Abstract available


  97. THE LANCET
    Cervical cancer prevention in Thailand-a model of success.
    Lancet. 2018;392:2.
    PubMed    


    June 2018
  98. LI A
    From Ireland to Northern Ireland: campaigns for abortion law.
    Lancet. 2018;391:2403-2404.
    PubMed    


  99. BOOTH A
    Argentina votes on bill to legalise abortion up to 14 weeks.
    Lancet. 2018;391:e21-e22.
    PubMed    


  100. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed    


    May 2018
  101. HALLGARTEN L
    Abortion narratives: moving from statistics to stories.
    Lancet. 2018 May 8. pii: S0140-6736(18)31036.
    PubMed    


  102. SPERBER A
    El Salvador's total ban on abortion risks women's health.
    Lancet. 2018;391:1758-1759.
    PubMed    


    April 2018
  103. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed    


    March 2018
  104. THE LANCET
    Diagnosis of heavy menstrual bleeding: a change in direction.
    Lancet. 2018;391:1122.
    PubMed    


  105. THE LANCET
    Abortion: access and safety worldwide.
    Lancet. 2018;391:1121.
    PubMed    


  106. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    PubMed    


    February 2018
  107. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
    Management of pregnancy loss in the first trimester: a retrospective audit.
    Lancet. 2018;391 Suppl 2:S34.
    PubMed     Abstract available


  108. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
    Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
    Lancet. 2018;391 Suppl 2:S26.
    PubMed     Abstract available


  109. KATEEB E, Momany E
    Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S11.
    PubMed     Abstract available


  110. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    PubMed    


  111. DEVI S
    FGM in Sierra Leone.
    Lancet. 2018;391:415.
    PubMed    


    December 2017
  112. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
    Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
    Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
    PubMed     Abstract available


  113. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
    Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
    PubMed     Abstract available


  114. KVASKOFF M, Horne AW, Missmer SA
    Informing women with endometriosis about ovarian cancer risk.
    Lancet. 2017;390:2433-2434.
    PubMed    


    November 2017
  115. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    PubMed    


  116. NANDI A, El-Toukhy T
    Stimulated intrauterine insemination for unexplained subfertility.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
    PubMed    


  117. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
    Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
    PubMed     Abstract available


  118. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
    Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
    PubMed     Abstract available


  119. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    PubMed    


  120. HEININGER U
    Syphilis in children.
    Lancet. 2017;390:2035-2036.
    PubMed    


    October 2017
  121. REGAN L, Glasier A
    The British 1967 Abortion Act-still fit for purpose?
    Lancet. 2017;390:1936-1937.
    PubMed    


  122. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed    


    September 2017
  123. CASASSUS B
    Contraception implant removed from global market.
    Lancet. 2017;390:1576.
    PubMed    


  124. GEMZELL-DANIELSSON K, Cleeve A
    Estimating abortion safety: advancements and challenges.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
    PubMed    


  125. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
    Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
    PubMed     Abstract available


  126. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    PubMed    


  127. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    PubMed     Abstract available


  128. DIZON DS
    PARP inhibitors for targeted treatment in ovarian cancer.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
    PubMed    


  129. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
    Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
    PubMed     Abstract available


  130. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed    


  131. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Abstract available


    July 2017
  132. BANERJEE S
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    PubMed    


  133. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    PubMed     Abstract available


    April 2017
  134. THE LANCET
    Syphilis: an ancient disease in a modern era.
    Lancet. 2017;389:1492.
    PubMed    


    December 2016
  135. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: